Saturday, May 25, 2013 Last update: 8:34 AM
Company Tech News as it Breaks
Trade Events
BioTime, Inc.
News articles for BioTime, Inc.:
Monday, May 20, 2013
- BioTime CEO Dr. Michael West to Present at USC Minisymposium: Musculoskeletal Development and RepairBioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, ... read more
Tuesday, May 14, 2013
- BioTime Appoints Franklin Berger to Board of DirectorsBioTime, Inc. (NYSE MKT: BTX) today announced that Franklin M. Berger, CFA, 63, has been appointed to its Board of Directors. ... read more
Monday, May 13, 2013
- BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief ScientistBioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences) today announced that Cell Cure Neurosciences has been awarded a grant of 5.34 ... read more
Friday, May 10, 2013
- BioTime Announces First Quarter 2013 Financial Results and Recent Corporate AccomplishmentsBioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the first quarter ended ... read more
Tuesday, May 7, 2013
- BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes ResearchBioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents™ portal (http://bioreagents.lifemapsc.com/) featuring an ... read more
Tuesday, April 30, 2013
- LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.10LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.10. The new release is available at www.genecards.org. ... read more
Monday, April 29, 2013
- BioTime Announces CFO Succession PlanBioTime, Inc. (NYSE MKT: BTX) announced today that its Senior Vice President and Chief Operating Officer, Robert W. Peabody, will reassume the additional role of Chief Financial Officer ... read more
Thursday, April 18, 2013
- LifeMap Sciences Announces Publication of Research Report Describing the MalaCards Database of Human DiseasesLifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that its MalaCards database has been recognized in a published paper by the Weizmann Institute ... read more
Wednesday, April 10, 2013
- LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGeneLifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that it is now offering 100 selected ProSpec-Tany TechnoGene (ProSpec) manufactured recombinant proteins related to ... read more
Monday, March 18, 2013
- BioTime Announces Fourth Quarter and Fiscal Year End 2012 Financial Results and Recent Corporate AccomplishmentsBioTime, Inc. (NYSE MKT: BTX), today reported financial results for the fourth quarter and year ended December 31, 2012 and highlighted its fourth quarter and recent corporate accomplishments. ... read more
Wednesday, March 13, 2013
- BioTime to Present at 25th Annual ROTH ConferenceBioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Dr. Michael D. West, Chief Executive ... read more
Tuesday, March 12, 2013
- BioTime Appoints Stephen C. Farrell to Board of DirectorsBioTime, Inc. (NYSE MKT: BTX) today announced that Stephen C. Farrell has been appointed to its Board of Directors. “We are ... read more
Thursday, March 7, 2013
- BioTime and Romulus Agree to Accelerate Closing Date for Second Tranche of $5 Million FinancingBioTime, Inc. (NYSE MKT: BTX) today announced it has amended its $5 million Stock and Warrant Purchase Agreement with Romulus Films, Ltd., originally signed on January 4, 2013. ... read more
Monday, March 4, 2013
- BioTime and Subsidiary LifeMap Sciences Announce Data Mining CollaborationBioTime, Inc. (NYSE MKT: BTX) and its bioinformatics subsidiary LifeMap Sciences, Inc. (“LifeMap”) today announced that they have entered into a definitive collaboration agreement to utilize LifeMap’s computer-based ... read more
Monday, February 11, 2013
- LifeMap Sciences, a Subsidiary of BioTime, Reports Its Databases Currently Utilized by an Estimated Two Million Unique Visitors Annually according to Google AnalyticsLifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), announced today that according to Google Analytics, the Company’s databases have attracted over two million unique visitors in ... read more
Thursday, January 31, 2013
- BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic Product PanC-DxTMBioTime, Inc. (NYSE MKT: BTX) and BioTime’s subsidiary OncoCyte Corporation provided an update on the progress of development of PanC-DxTM, a novel blood-based diagnostic test utilizing molecular markers ... read more
Wednesday, January 30, 2013
- LifeMap Sciences, a Subsidiary of BioTime, Announces Publication of Research Report Describing Non-Redundant Compendium of Human Non-Coding RNA Authored by GeneCards® ScientistsLifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the publication of a paper authored by a research group under the supervision of Prof. ... read more
Friday, January 18, 2013
- BioTime CEO Dr. Michael West to Present at Scale-Up and Manufacturing of Cell-Based Therapies II ConferenceBioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, ... read more
Thursday, January 10, 2013
- BioTime Submits Protocol for Initiation of Human Clinical Trials of Renevia™ in EuropeBioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced it has submitted a Clinical Investigation Protocol ... read more
Wednesday, January 9, 2013
- LifeMap Sciences, a Subsidiary of BioTime, Inc., Announces the Release of MalaCards Version 1.02LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of MalaCards version 1.02 on January 7. The new release is available at ... read more